Click here to go to the previous page
Evolving to Functional Service Providers (FSP): Successfully Transforming Existing Partnerships into FSP Relationships
Program Code:
304
Date:
Wednesday, June 26, 2013
Time:
8:00 AM to 9:30 AM
EST
CHAIR
:
Andrew Townshend,
(SCHNON), Vice President, Alliance Development,
INC Research, United States
Vice President of Alliance Development at INC Research. Mr. Townshend has responsibility for developing strategic accounts within the Pharma and biotech industries focused on novel and innovative engagement and alliance models. Prior to this, Mr. Townshend was Vice President Outsourcing at Pfizer .
|
SPEAKER
(S):
Peter A. Carberry,
MD,MBA (SPKNON), Senior Vice President, Global Development Operations,
Astellas Pharma Global Development, Inc., United States
Peter completed medical and surgery training at the University of Nairobi, Kenya. He completed postdoc fellowship in Clinical Pharmacology at Univ. of Texas in 1991 and his MBA from Western Michigan University in 2000. He has 18 years of industry experience in Clinical Development.
|
Gregg Dearhammer, (SPKNON), InVentiv Health Clinical, United States
Gary J. Thompson, Eli Lilly and Company, United States
Description
As expertise continues to transfer from pharma to CROs, how can the industry continue to drive improvement and innovation? One approach is the evolution of functional service provider (FSP) relationships. This forum brings together experts to discuss their successful approaches.